First Trust Advisors LP Has $53.93 Million Stake in Bruker Corporation $BRKR

First Trust Advisors LP lifted its stake in Bruker Corporation (NASDAQ:BRKR) by 32.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,493,053 shares of the medical research company’s stock after buying an additional 366,187 shares during the period. First Trust Advisors LP’s holdings in Bruker were worth $53,929,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in BRKR. Dimensional Fund Advisors LP increased its stake in Bruker by 23.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,341,518 shares of the medical research company’s stock worth $84,556,000 after acquiring an additional 448,440 shares during the period. Swiss National Bank grew its holdings in shares of Bruker by 0.5% during the 1st quarter. Swiss National Bank now owns 210,500 shares of the medical research company’s stock worth $7,603,000 after purchasing an additional 1,000 shares in the last quarter. SteelPeak Wealth LLC acquired a new stake in shares of Bruker during the 1st quarter worth $875,000. Allspring Global Investments Holdings LLC increased its position in shares of Bruker by 19.9% in the first quarter. Allspring Global Investments Holdings LLC now owns 306,396 shares of the medical research company’s stock worth $11,055,000 after purchasing an additional 50,955 shares during the period. Finally, Bastion Asset Management Inc. acquired a new position in Bruker in the first quarter valued at about $777,000. Institutional investors and hedge funds own 79.52% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. UBS Group set a $60.00 price objective on shares of Bruker in a research report on Wednesday, June 24th. Leerink Partners raised their target price on shares of Bruker from $60.00 to $70.00 and gave the company an “outperform” rating in a report on Tuesday, July 7th. Wall Street Zen upgraded shares of Bruker from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Stifel Nicolaus set a $45.00 price target on shares of Bruker in a report on Friday, May 8th. Finally, JPMorgan Chase & Co. increased their price target on shares of Bruker from $55.00 to $65.00 and gave the stock an “overweight” rating in a research report on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $56.79.

Bruker Price Performance

Shares of BRKR stock opened at $60.45 on Monday. The business has a fifty day simple moving average of $56.32 and a 200 day simple moving average of $46.29. The company has a market cap of $9.20 billion, a P/E ratio of -251.88, a P/E/G ratio of 1.94 and a beta of 1.29. The company has a quick ratio of 0.72, a current ratio of 1.55 and a debt-to-equity ratio of 0.67. Bruker Corporation has a twelve month low of $28.53 and a twelve month high of $64.54.

Bruker (NASDAQ:BRKR) last issued its earnings results on Wednesday, May 6th. The medical research company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.23 by $0.08. The firm had revenue of $823.40 million during the quarter, compared to the consensus estimate of $795.62 million. Bruker had a positive return on equity of 11.60% and a negative net margin of 0.65%.The business’s quarterly revenue was up 2.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.47 earnings per share. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. On average, sell-side analysts forecast that Bruker Corporation will post 2.12 EPS for the current fiscal year.

Bruker Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, July 7th. Shareholders of record on Monday, June 22nd were given a $0.05 dividend. The ex-dividend date was Monday, June 22nd. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Bruker’s dividend payout ratio (DPR) is currently -83.33%.

Bruker Profile

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.